The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Synthon
A NKG2D-based CAR-T therapy in a multinational phase I dose escalation and expansion study targeting multiple solid and hematologic tumor types.
 
Bikash Verma
Employment - Celyad
Leadership - Celyad
Stock and Other Ownership Interests - Celyad
Travel, Accommodations, Expenses - Celyad
 
Philippe Georges Aftimos
No Relationships to Disclose
 
Ahmad Awada
No Relationships to Disclose
 
Jean-Pascal H. Machiels
Consulting or Advisory Role - Boehringer Ingelheim; Debiopharm Group; Merck Sharp & Dohme; Nanobiotix; Pfizer
Research Funding - Bayer; Janssen; Novartis; Sanofi
 
Jason B. Brayer
No Relationships to Disclose
 
David A Sallman
Research Funding - Celgene
 
Tessa Kerre
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Celgene (Inst)
Travel, Accommodations, Expenses - Celgene; CSL Behring
 
Kunle Odunsi
Research Funding - ITeos Therapeutics (Inst)
 
Caroline Lonez
Employment - Celyad
Stock and Other Ownership Interests - Celyad
 
David Edward Gilham
Employment - Celyad
Leadership - Celyad
Stock and Other Ownership Interests - Celyad
Consulting or Advisory Role - Celyad; Oxford Biomedica
Research Funding - GlaxoSmithKline; Grant Funded Research (UK); Oxford Biomedica
Travel, Accommodations, Expenses - Celyad
 
Frederic Lehmann
Employment - Celyad
Leadership - Celyad; GlaxoSmithKline
Stock and Other Ownership Interests - Celyad; GlaxoSmithKline
Honoraria - Celyad; GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - Patent and IP at GSK
Travel, Accommodations, Expenses - Celyad; GlaxoSmithKline